Purpose

Longwood Fund is one of the top-performing healthcare venture capital firms that founds, manages, and builds healthcare companies.

Longwood’s mission is to identify technologies and found companies that make a difference in the lives of patients, and also create significant value for investors. The Longwood team has a consistent, long history of successfully launching and building leading healthcare companies and providing operational leadership and strategic guidance. Christoph Westphal MD, PhD, has served as co-founder, CEO, and lead investor of six companies (including Alnylam, Acceleron, Sirtris, and Momenta) that have completed IPOs, yielding an aggregate, sustained, value of ~$16 billion. Rich Aldrich was a co-founder of Vertex Pharmaceuticals, which currently has a market capitalization of ~$60 billion.